Navigation Links
The Chronic Pain Drug Market Will Attain $21.6 Billion in Major-Market Sales by 2022
Date:12/12/2013

BURLINGTON, Mass., Dec. 12, 2013 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that the chronic pain drug market will decrease from $21.4 billion in 2012 to $18.3 billion in 2017, but will recover to $21.6 billion by 2022 in the United States, France, Germany, Italy, Spain, the United Kingdom and Japan.

(Logo: http://photos.prnewswire.com/prnh/20130103/MM36784LOGO )

"The sales pattern in the total chronic pain market is attributable to the loss of market exclusivity for key chronic pain therapies, including controlled-release oxycodone (Purdue Pharma/Mundipharma/Napp Pharmaceuticals' OxyContin), over the next five years," said Decision Resources Principal Business Insights Analyst Natalie Taylor, Ph.D. "Market contraction in the first half of the forecast period will be followed by a growth in sales from 2017 through 2022, driven by the launches of a number of emerging therapies."

The Pharmacor report entitled Chronic Pain also finds that the pipeline of therapies in clinical development for chronic pain conditions continues to be composed largely of reformulations of existing molecules—however, agents with novel mechanisms of action, such as subtype-selective sodium channel blockers and monoclonal antibodies against nerve growth factor (NGF), have made recent and notable developmental advances. Overcoming delays due to safety concerns, anti-NGF therapies such as Eli Lilly/Pfizer's tanezumab and Johnson & Johnson/Takeda's fulranumab are forecast to g
'/>"/>

SOURCE Decision Resources
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Ibrutinib Data Published in The Lancet Oncology Suggest a Positive Effect in Previously Untreated Chronic Lymphocytic Leukemia Patients Over Age 65
2. Highland Instruments, Inc., Announces Presentation of "Effects of Electrosonic Stimulation on the Perception of Chronic Pain Due to Osteoarthritis of the Knee."
3. Improved Efficacy, Limited Toxicity of Targeted Therapies Brighten the Future of Treatment for Chronic Lymphocytic Leukemia
4. Novartis highlights research on investigational, personalized T cell therapy CTL019 in patients with forms of acute and chronic leukemia
5. Shield Therapeutics Files Investigational New Drug Application for ST10 for the Treatment of Iron Deficiency in Chronic Kidney Disease
6. Simeprevir Administered Once Daily as Part of Combination Therapy Demonstrates Sustained Virologic Response in Treatment-Naive and Treatment-Experienced Genotype 1 Chronic Hepatitis C Adult Patients
7. West to Co-present Research Findings on Understanding the Patient Journey through the Phases of a Chronic Disease
8. More than a Third of Chronic Kidney Disease-Non-Dialysis Patients are Likely Candidates for FG-4592/ASP1517, According to Surveyed EU5 Nephrologists
9. Is Chronic Pain Keeping You Awake? Help Is On the Way
10. Chronic Use of Prescription Painkillers Continues Following Bariatric Surgery
11. Bayers Investigational Drug Riociguat Granted FDA Orphan Drug Designation for Treatment of Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/1/2014)... , Aug. 1, 2014 MGC ... technologies company, announced today that it has completed ... manufacturer of cardiorespiratory diagnostic products based in Sorinnes, ... has served the European cardiorespiratory diagnostics market since ... revenues of approximately €4.7 million ($6.3 million) and ...
(Date:8/1/2014)... , Aug. 1, 2014  NxStage Medical, Inc. (Nasdaq: ... today announced that Jeffrey H. Burbank , Chief Executive ... present at the 34 th Annual Canaccord Genuity Growth ... MA , on Wednesday, August 13 th at ... made available at http://ir.nxstage.com/ .  About ...
(Date:8/1/2014)... -- Isis Pharmaceuticals, Inc. (NASDAQ: ISIS ) announced ... evaluating ISIS-SMN Rx in infants with spinal muscular ... mortality. Isis plans to dose the first infant in ... time Isis will earn an $18 million milestone payment ... study, ENDEAR, is the first of several planned studies ...
Breaking Medicine Technology:MGC Diagnostics Corporation Completes Acquisition of MediSoft SA 2MGC Diagnostics Corporation Completes Acquisition of MediSoft SA 3MGC Diagnostics Corporation Completes Acquisition of MediSoft SA 4NxStage to Present at the 34th Annual Canaccord Genuity Growth Conference 2Isis Pharmaceuticals Initiates Phase 3 Study of ISIS-SMN Rx in Infants with Spinal Muscular Atrophy 2Isis Pharmaceuticals Initiates Phase 3 Study of ISIS-SMN Rx in Infants with Spinal Muscular Atrophy 3Isis Pharmaceuticals Initiates Phase 3 Study of ISIS-SMN Rx in Infants with Spinal Muscular Atrophy 4Isis Pharmaceuticals Initiates Phase 3 Study of ISIS-SMN Rx in Infants with Spinal Muscular Atrophy 5
... - First prospective biomarker trial in non-small cell ... /PRNewswire-FirstCall/ -- Response,Genetics, Inc. today announced that positive ... issue of the Journal of Clinical,Oncology suggests that ... in patient biopsies,with advanced non-small cell lung cancer ...
... been,specifically designed by scientists to be safe to normal ... a preliminary study,researchers said today at the ESMO Conference ... type of herpes simplex virus,modified so that it selectively ... "It doesn't replicate in normal, healthy cells, so our ...
Cached Medicine Technology:Response Genetics Announces Publication of a Phase III Clinical,Trial Demonstrating That Low Levels of ERCC-1 Help to Predict,Likelihood of Response to Cisplatin-Based Therapy in Lung Cancer 2Response Genetics Announces Publication of a Phase III Clinical,Trial Demonstrating That Low Levels of ERCC-1 Help to Predict,Likelihood of Response to Cisplatin-Based Therapy in Lung Cancer 3Response Genetics Announces Publication of a Phase III Clinical,Trial Demonstrating That Low Levels of ERCC-1 Help to Predict,Likelihood of Response to Cisplatin-Based Therapy in Lung Cancer 4MediGene Announces Cancer-Fighting Virus Shows Promise in Early,Clinical Trial 2MediGene Announces Cancer-Fighting Virus Shows Promise in Early,Clinical Trial 3MediGene Announces Cancer-Fighting Virus Shows Promise in Early,Clinical Trial 4MediGene Announces Cancer-Fighting Virus Shows Promise in Early,Clinical Trial 5
(Date:8/1/2014)... York City, NY (PRWEB) August 01, 2014 ... for two incomes, and the convenience of processed, microwavable dinners, ... epidemic. Diet Doc does not offer patients a mere quick ... about helping everyone, in any part of the country, get ... that if they offer patients the tools and education on ...
(Date:8/1/2014)... Pompano Beach, FL (PRWEB) August 01, 2014 ... capsules, announced today the opening of a new ... Canada. , The company announced expansion plans last ... products. According to Dale Martin, General Manager, “KCAPS® ... around the world.” He added that: “Compared to ...
(Date:8/1/2014)... St. Christopher's Hospital for Children announced that they ... with Ed Begley Jr, airing later this year 2014, ... St. Christopher's Hospital for Children offers a wide range ... 21 years of age. With over 220 pediatric specialists, ... autism and childhood obesity. , “St. Christopher’s is ...
(Date:8/1/2014)... 01, 2014 A new study ... carbohydrates may contribute to the development of colorectal cancer ... disease. The study was authored by Alberto Martin of ... to cause intestinal cells to multiply and create tumors ... cancer. , “What’s interesting about this study,” said ...
(Date:8/1/2014)... For many people, forgetfulness becomes more ... within the normal range, slips that seem new or ... This merits a closer look, not a panic attack, ... Harvard Men's Health Watch . , "We don't ... their keys are they are on the path to ...
Breaking Medicine News(10 mins):Health News:Diet Doc Medical Weight Loss Programs Announces Diet Plans That Melt Excess Fat Rapidly While Teaching Patients How to Avoid Obesity 2Health News:Diet Doc Medical Weight Loss Programs Announces Diet Plans That Melt Excess Fat Rapidly While Teaching Patients How to Avoid Obesity 3Health News:Innovations with Ed Begley, Jr. to Feature St. Christopher's Hospital for Children in Upcoming Episode 2Health News:Innovations with Ed Begley, Jr. to Feature St. Christopher's Hospital for Children in Upcoming Episode 3Health News:Carbs May Contribute to Colon Cancer 2Health News:Worried About Changes in Your Memory? It's Worth A Closer Look, From the August 2014 Harvard Men's Health Watch 2
... brain scans to try and study the biology of dread. ... brain pays to the expected pain // determines and whether ... that simple diversions could alleviate the misery. ,The ... new field called neuroeconomics that uses brain imaging to try ...
... Baeg Moon-hong. He is a senior researcher at the Korea ... was show cased in an exhibition at the Seoul Education ... meters tall. The special features are that it can understand ... expressions. , The first android was made by ...
... the shaking leg syndrome is a common type of disorder in ... For the first time Europe has approved the drug to be ... aches and pains. Statistics show that about 10% of the people ... by the European Medicines Agency. As of now it is used ...
... Health conscious people here lawyers in California have sued PepsiCo ... benzene//., ,The drink in question is Pepsi Twist drink, ... three' soft drinks firms has been drawn into a legal ... the lawsuit, "Pepsi Twist has been falsely promoted as a ...
... the Supreme Court Friday reversed an earlier order directing ... all-India basis// for scheduled castes and scheduled tribes candidates ... ,A bench of judges K.G. Balakrishnan, A.R. Lakshmanan ... General Gopal Subramaniam that enforcing the 10 percent quota ...
... kid of Orissa, declared that his health is normal. // ... up after he ran an astounding 65km earlier this week. ... at Bhubaneswar for a medical check up on the orders ... coach Biranchi Das was exploiting the boy for his personal ...
Cached Medicine News:Health News:Supreme Court Quashed Reservation Quotas For PG Medical Courses 2Health News:Marathon Kid Budhia’s Health Not Compromise 2
...
...
EDM Lumbar Drainage Kit with and without Bioglide are fabricated of radiopaque (barium impregnated) silicone tubing, and are packaged with stainless steel stylets inserted in the lumen....
Medtronic neurosurgery external drainage and monitoring (EDM) products meet a variety of needs for CSF drainage and monitoring....
Medicine Products: